Oklo Inc. OKLO
4 trading plans running, 58 Form 144 notices for $331.1M
10-Q, 10-K and Form 144What OKLO's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Mar 31, 2025 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Caroline DeWitte Chief Operating Officer and a director |
Adopted 10b5-1 plan | Sep 29, 2026 | 10-Q Nov 6, 2026 | ||
What the company wroteOn September 29, 2026, trusts associated with Jacob DeWitte, the Company's Chief Executive Officer and a director, and Caroline DeWitte, the Company's Chief Operating Officer and a director, adopted a Rule 10b5-1 trading arrangement. The arrangement provides for the sale of an aggregate of up to 2,500,000 shares of the Company's common stock, consisting of 1,250,000 shares allocated to the Jacob DeWitte Family Trust and Jacob DeWitte Grantor Retained Annuity Trust No. 1 and 1,250,000 shares allocated to the Caroline DeWitte Family Trust and Caroline DeWitte Grantor Retained Annuity Trust No. 1. Sales are scheduled to begin on January 12, 2027, subject to certain commencement conditions, and continue through December 31, 2027, subject to earlier termination in accordance with its terms. | |||||
| Jacob DeWitte Chief Executive Officer and a director |
Adopted 10b5-1 plan | Sep 29, 2026 | 10-Q Nov 6, 2026 | ||
What the company wroteOn September 29, 2026, trusts associated with Jacob DeWitte, the Company's Chief Executive Officer and a director, and Caroline DeWitte, the Company's Chief Operating Officer and a director, adopted a Rule 10b5-1 trading arrangement. The arrangement provides for the sale of an aggregate of up to 2,500,000 shares of the Company's common stock, consisting of 1,250,000 shares allocated to the Jacob DeWitte Family Trust and Jacob DeWitte Grantor Retained Annuity Trust No. 1 and 1,250,000 shares allocated to the Caroline DeWitte Family Trust and Caroline DeWitte Grantor Retained Annuity Trust No. 1. Sales are scheduled to begin on January 12, 2027, subject to certain commencement conditions, and continue through December 31, 2027, subject to earlier termination in accordance with its terms. | |||||
| R. Craig Bealmear Chief Financial Officer |
Adopted 10b5-1 plan | Aug 11, 2026 | 10-Q Nov 6, 2026 | ||
What the company wroteOn August 11, 2026, R. Craig Bealmear, the Company's Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement providing for the exercise of stock options for an aggregate of 233,714 shares of the Company's common stock and "eligible sell-to-cover" transactions (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act) to satisfy tax withholding obligations arising exclusively from the exercise of such options. The transactions are scheduled to begin on February 1, 2027, with outstanding orders expiring on December 10, 2027 and the arrangement terminating no later than December 13, 2027, subject to early termination in accordance with its terms. | |||||
| William Goodwin Chief Legal and Strategy Officer |
Ended 10b5-1 plan | Jun 29, 2026 | 10-Q Aug 7, 2026 | ||
What the company wroteOn April 2, 2026, William Goodwin, the Company’s Chief Legal and Strategy Officer, materially modified the Rule 10b5-1 trading arrangement previously adopted by him on December 15, 2025 and previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Prior Trading Arrangement”). The Prior Trading Arrangement was intended to provide for “eligible sell-to-cover transactions” (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act) to satisfy tax withholding obligations arising exclusively from the vesting of equity awards and the related issuance of up to 13,620 shares of the Company’s common stock, and was scheduled to terminate on December 4, 2026, subject to early termination for certain specified events set forth therein. For purposes of Rule 10b5-1(c) under the Exchange Act, the April 2, 2026 modification constituted a termination of the Prior Trading Arrangement and the adoption of a new Rule 10b5-1 trading arrangement (the “Modified Trading Arrangement”) intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The Modified Trading Arrangement provided for the sale of up to 79,677 shares of the Company’s common stock and was scheduled to terminate on December 4, 2026, subject to early termination for certain specified events set forth therein. On June 29, 2026, Mr. Goodwin terminated the Modified Trading Arrangement. | |||||
| William Goodwin Chief Legal and Strategy Officer |
Adopted 10b5-1 plan | Dec 15, 2025 | 10-K Mar 17, 2026 | ||
What the company wroteOn December 15, 2025, William Goodwin, the Company’s Chief Legal and Strategy Officer, adopted a Rule 10b5-1 trading arrangement (the “Trading Arrangement”) intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The Trading Arrangement is intended to provide for “eligible sell-to-cover transactions” (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act) to satisfy tax withholding obligations arising exclusively from the vesting of equity awards and the related issuance of up to 13,620 shares of the Company’s common stock. The number of shares that will be sold to satisfy applicable tax withholding obligations upon vesting is not currently determinable as the number will vary based on the market price of the Company’s common stock and the extent to which vesting conditions are satisfied. The Trading Arrangement will terminate December 4, 2026, subject to early termination for certain specified events set forth in the Trading Arrangement. | |||||
| R. Craig Bealmear Chief Financial Officer |
Adopted 10b5-1 plan | Sep 22, 2025 | 10-Q Nov 12, 2025 | ||
What the company wroteOn September 22, 2025, R. Craig Bealmear, the Company’s Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement (the “Trading Arrangement”) intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The Trading Arrangement is intended to provide for “eligible sell-to-cover transactions” (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act) to satisfy tax withholding obligations arising exclusively from the vesting of equity awards and the related issuance of up to 233,714 shares of the Company’s common stock. The number of shares that will be sold to satisfy applicable tax withholding obligations upon vesting is not currently determinable as the number will vary based on the market price of the Company’s common stock and the extent to which vesting conditions are satisfied. The Trading Arrangement will terminate December 31, 2026, subject to early termination for certain specified events set forth in the Trading Arrangement. | |||||
| Caroline Cochran Chief Operating Officer |
Adopted 10b5-1 plan | Mar 31, 2025 | 10-Q May 13, 2025 | ||
What the company wroteCaroline Cochran, Chief Operating Officer, adopted a trading plan on March 31, 2025, which provides for the sale of up to 300,000 shares of Oklo common stock between June 30, 2025 and December 31, 2025, as well as the sale of up to 300,000 shares of common stock sold between September 30, 2025 and December 31, 2025, for an aggregate of up to 600,000 shares. | |||||
| Jacob DeWitte Chief Executive Officer |
Adopted 10b5-1 plan | Mar 31, 2025 | 10-Q May 13, 2025 | ||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 16 filings checked since May 15, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 13, 2026 | Narayanadas Vivek Officer |
936 | $22K |
| Nov 13, 2026 | Goodwin William Carroll Murphy Officer |
11,366 | $268K |
| Nov 13, 2026 | Webster Ryan Officer |
5,213 | $121K |
| Nov 2, 2026 | Bealmear Richard Craig Officer |
16,727 | $427K |
| Oct 29, 2026 | Hanson John Officer |
1,034 | $28K |
| Oct 29, 2026 | Renner Alexandra Officer |
1,068 | $29K |
| Oct 20, 2026 | Narayanadas Vivek Officer |
1,021 | $27K |
| Oct 19, 2026 | Narayanadas Vivek Officer |
2,359 | $65K |
| Oct 14, 2026 | Renner Alexandra Officer |
688 | $21K |
| Oct 9, 2026 | Narayanadas Vivek Officer |
364 | $13K |
| Oct 6, 2026 | Narayanadas Vivek Officer |
288 | $11K |
| Oct 5, 2026 | Narayanadas Vivek Officer |
649 | $23K |
| Oct 1, 2026 | Bealmear Richard Craig Officer |
16,477 | $608K |
| Sep 28, 2026 | Renner Alexandra Officer |
1,100 | $41K |
| Sep 28, 2026 | Hanson John Officer |
1,110 | $42K |
| Sep 28, 2026 | Goodwin William Carroll Murphy Officer |
1,775 | $66K |
| Sep 14, 2026 | Jansen John M Director |
6,354 | $233K |
| Sep 9, 2026 | Narayanadas Vivek Officer |
365 | $16K |
| Sep 8, 2026 | Narayanadas Vivek Officer |
238 | $10K |
| Sep 4, 2026 | Narayanadas Vivek Officer |
538 | $21K |
| Sep 1, 2026 | Renner Alexandra Officer |
1,930 | $74K |
| Sep 1, 2026 | Bealmear Richard Craig Officer |
16,430 | $637K |
| Aug 25, 2026 | Narayanadas Vivek Officer |
223 | $9K |
| Aug 24, 2026 | Goodwin William Carroll Murphy Officer |
11,592 | $461K |
| Aug 24, 2026 | Hanson John Officer |
539 | $21K |
| Aug 24, 2026 | Narayanadas Vivek Officer |
3,264 | $130K |
| Aug 24, 2026 | Renner Alexandra Officer |
557 | $22K |
| Aug 3, 2026 | Jacob DeWitte CEO / Director / 10% Shareholder |
400,000 | $15.5M |
| Aug 3, 2026 | Caroline Cochran COO / Director / 10% Shareholder |
400,000 | $15.5M |
| Aug 3, 2026 | Bealmear Richard Craig Officer |
16,452 | $638K |
| Jul 1, 2026 | Bealmear Richard Craig Officer |
16,321 | $875K |
| Jun 1, 2026 | Bealmear Richard Craig Officer |
56,843 | $3.9M |
| Jun 1, 2026 | Bealmear Richard Craig Officer |
16,238 | $1.1M |
| May 21, 2026 | Schweiger Patrick Joseph Former Officer |
20,044 | $1.3M |
| May 20, 2026 | Schweiger Patrick Joseph Officer |
459 | $27K |
| May 20, 2026 | Goodwin William Carroll Murphy Officer |
10,548 | $612K |
| May 1, 2026 | Caroline Cochran COO / Director / 10% Shareholder |
300,000 | $21.8M |
| May 1, 2026 | Jacob DeWitte CEO / Director / 10% Shareholder |
300,000 | $21.8M |
| May 1, 2026 | Bealmear Richard Craig Officer |
16,216 | $1.1M |
| Apr 1, 2026 | Bealmear Richard Craig Officer |
16,342 | $835K |
| Mar 27, 2026 | Jansen John M Director |
10,500 | $541K |
| Mar 27, 2026 | Kinzley Richard Director |
4,000 | $208K |
| Mar 25, 2026 | Goodwin William Carroll Murphy Officer |
10,639 | $601K |
| Mar 25, 2026 | Schweiger Patrick Joseph Officer |
5,561 | $314K |
| Mar 13, 2026 | Cochran Caroline Officer, Director |
44,828 | $2.7M |
| Mar 13, 2026 | DeWitte Jacob Officer, Director |
72,960 | $4.4M |
| Mar 13, 2026 | Bealmear Richard Craig Officer |
72,090 | $4.3M |
| Mar 9, 2026 | Goodwin William Carroll Murphy Officer |
2,820 | $160K |
| Mar 2, 2026 | Bealmear Richard Craig Officer |
16,527 | $975K |
| Feb 2, 2026 | Bealmear Richard Craig Officer |
9,726 | $748K |
| Jan 7, 2026 | Caroline Cochran COO / Director / 10% Shareholder |
655,000 | $62.6M |
| Jan 7, 2026 | Jacob DeWitte CEO / Director / 10% Shareholder |
655,000 | $62.6M |
| Dec 22, 2025 | Caroline Cochran COO / Director / 10% Shareholder |
570,000 | $47.4M |
| Dec 22, 2025 | Jacob DeWitte CEO / Director / 10% Shareholder |
570,000 | $47.4M |
| Dec 18, 2025 | Bealmear Richard Craig Officer |
5,159 | $397K |
| Dec 17, 2025 | Bealmear Richard Craig Officer |
69,841 | $5.5M |
| Dec 1, 2025 | Goodwin William Carroll Murphy Officer |
5,864 | $519K |
| Nov 19, 2025 | Goodwin William Carroll Murphy Officer |
11,936 | $1.2M |
Show the other 50 notices
From the Form 144 XML filed with the SEC, since Nov 19, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OKLO/export.csv") into a cell.